Researchers in Norway have found that repeated intravitreal injections (IVI) with anti-vascular endothelial growth factor (anti-VEGF) improved some dry-eye disease symptoms in patients with neovascular age-related macular degeneration (nAMD).
Despite conflicting results from previous studies, a new review of 152 publications concluded topical omega-3 is a promising treatment option for dry eye disease (DED) and other ocular surface inflammatory disease.
A US pilot study has shown that low-dose doxycycline, an antibiotic with anti-inflammatory characteristics used to treat bacterial infections, meibomian gland dysfunction and rosacea, may be a useful adjunct therapy for intraocular pressure (IOP) reduction.
Telemedicine in oculoplastic and adnexal surgery: clinicians’ perspectives in the UK
California-based ophthalmic medical company Glaukos announced promising topline results from its phase 2a first-in-human clinical trial for GLK-301 (iLution), a sterile topical cream to treat dry eye disease (DED). The cream formulation acts as a depot allowing pilocarpine to be delivered through th
After almost three years of Covid restrictions on international travel, it was such a pleasure to join thousands of in-person attendees at the San Diego Convention Centre for the four-day American Academy of Optometry (AAO) 2022 meeting.
Novaliq has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for CyclASol, which it describes as a first-of-its-kind anti-inflammatory product for the treatment of dry eye disease (DED).
Israel’s Azura Ophthalmics announced positive three-month efficacy and safety results from its phase 2b study on its keratolytic eye preparation AZR-MD-001 0.5% in meibomian gland dysfunction (MGD).
There was a time when refractive surgery was very much the domain of those surgeons who specifically specialised in excimer laser treatment of the cornea, but rapid advances in corneal refractive surgery techniques and intraocular lens (IOL) technology, as well as greater patient expectations, have
Boosting its dry eye family of products, Medix21 has introduced Rayner’s Aeon pre- and post-surgery eye drops to help manage patients’ dry eye and improve visual outcomes.
Sharing the spotlight with its dry eye diagnostics, Ophthalmic Instrument Company (OIC) introduced Avizor’s Ever Clean Plus lens care system to New Zealand’s ophthalmic community at this year’s CCLS conference.
Dry eye disease (DED) occurs more frequently in women than in men and it’s recognised that hormones play an important role in the health and preservation of ocular surface tissues. Studies have demonstrated a direct link between hormones and susceptibility to DED1-4, linked to the presence of sex-st
